Zhejiang Qianjiang Biochemical Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Chemicals & Petrochemicals
  • ISIN: CNE000000PG1
CNY
6.18
0.02 (0.32%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
1,688.50
1,765.34
2,030.44
2,005.66
2,015.37
1,869.70
380.16
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,688.50
1,765.34
2,030.44
2,005.66
2,015.37
1,869.70
380.16
Raw Material Cost
1,292.83
1,387.22
1,585.46
1,597.18
1,587.42
1,491.90
338.90
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
65.85
86.12
97.55
103.27
96.49
95.17
3.40
Selling and Distribution Expenses
161.99
177.88
161.70
125.77
120.44
129.71
62.48
Other Expenses
-4.17
-5.85
-7.20
-7.50
-6.86
-7.97
0.84
Total Expenditure (Excl Depreciation)
1,478.91
1,592.73
1,772.75
1,751.26
1,735.76
1,637.09
413.18
Operating Profit (PBDIT) excl Other Income
209.60000000000002
172.60000000000002
257.7
254.4
279.6
232.60000000000002
-33
Other Income
75.21
48.95
31.21
49.82
23.76
50.84
90.97
Operating Profit (PBDIT)
464.37
449.16
512.15
528.68
490.54
447.57
88.38
Interest
65.85
86.12
97.55
103.27
96.49
95.17
3.40
Exceptional Items
0.03
2.17
-5.35
0.73
3.32
-6.21
-8.74
Gross Profit (PBDT)
395.67
378.13
444.98
408.48
427.95
377.80
41.27
Depreciation
197.17
238.42
228.36
238.11
187.65
171.46
45.28
Profit Before Tax
201.38
126.79
180.89
188.04
209.73
174.74
30.96
Tax
45.76
48.98
45.94
50.17
46.98
51.87
4.19
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
166.36
160.00
210.69
206.05
147.94
96.14
19.18
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
166.36
160.00
210.69
206.05
147.94
96.14
19.18
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-10.72
-34.65
-27.79
-15.95
14.81
26.85
7.39
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
155.65
125.35
182.90
190.10
162.75
122.98
26.57
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
3,440.05
3,276.18
3,138.13
3,014.59
2,893.00
1,861.77
597.09
Earnings per share (EPS)
0.19
0.18
0.24
0.24
0.17
0.32
0.06
Diluted Earnings per share
0.19
0.18
0.24
0.24
0.17
0.32
0.06
Operating Profit Margin (Excl OI)
11.37%
9.16%
12.44%
12.0%
13.85%
12.05%
-12.59%
Gross Profit Margin
23.6%
20.69%
20.16%
21.25%
19.72%
18.52%
20.06%
PAT Margin
9.85%
9.06%
10.38%
10.27%
7.34%
5.14%
5.05%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is -4.35% vs -13.06% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is 24.08% vs -31.44% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is -2.75% vs -16.78% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is -23.58% vs -11.78% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has improved from Dec 2024

Compare Annual Results Of Zhejiang Qianjiang Biochemical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
1,688.50
0
1,688.50
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,688.50
0
1,688.50
Raw Material Cost
1,292.83
0
1,292.83
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
65.85
0
65.85
Selling and Distribution Expenses
161.99
0
161.99
Other Expenses
-4.17
0.00
-4.17
Total Expenditure (Excl Depreciation)
1,478.91
0
1,478.91
Operating Profit (PBDIT) excl Other Income
209.59
0.00
209.59
Other Income
75.21
0
75.21
Operating Profit (PBDIT)
464.37
0
464.37
Interest
65.85
0
65.85
Exceptional Items
0.03
0
0.03
Gross Profit (PBDT)
395.67
0
395.67
Depreciation
197.17
0
197.17
Profit Before Tax
201.38
0
201.38
Tax
45.76
0
45.76
Provisions and contingencies
0
0
0.00
Profit After Tax
166.36
0
166.36
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
166.36
0
166.36
Share in Profit of Associates
0
0
0.00
Minority Interest
-10.72
0
-10.72
Other related items
0.00
0.00
0.00
Consolidated Net Profit
155.65
0
155.65
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
3,440.05
0
3,440.05
Earnings per share (EPS)
0.19
0
0.19
Diluted Earnings per share
0.19
0
0.19
Operating Profit Margin (Excl OI)
11.37%
0%
0.00
11.37%
Gross Profit Margin
23.60%
0%
0.00
23.60%
PAT Margin
9.85%
0%
0.00
9.85%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 168.85 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -4.35% vs -13.06% in Dec 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 15.56 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 24.08% vs -31.44% in Dec 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 38.92 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -2.75% vs -16.78% in Dec 2024

Annual - Interest
Interest 6.58 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -23.58% vs -11.78% in Dec 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 11.37%
in Dec 2025

Figures in %
stock-summary

YoY Growth in year ended Dec 2025 has improved from Dec 2024